Decompressive percutaneous endoscopic gastrostomy in advanced cancer patients with small-bowel obstruction is feasible and effective: a large prospective study

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Elena ZucchiR Cannizzaro

Abstract

The purpose of this study was to evaluate patient-centered outcomes of decompressive percutaneous endoscopic gastrostomy (dPEG) in patients with malignant bowel obstruction due to advanced gynecological and gastroenteric malignancies. This is a prospective analysis of 158 consecutive patients with small-bowel obstruction from advanced gynecological and gastroenteric cancer who underwent PEG or percutaneous endoscopic jejunostomy (PEJ) positioning for decompressive purposes from 2002 to 2012. All of them had previous abdominal surgery and were unfit for any other surgical procedures. Symptom relief, procedural complications, and post dPEG palliation were assessed. Global Quality of Life (QoL) was evaluated in the last 2 years (25 consecutive patients) before and 7 days after dPEG placement using the Symptom Distress Scale (SDS). dPEG was successfully performed in 142 out of 158 patients (89.8 %). Failure of tube placement occurred in 16 patients (10.1 %). In 8/142 (5.6 %) patients, dPEG was guided by abdominal ultrasound. In 3/142 patients, dPEG was CT-guided. In 14 (9.8 %) patients, who had previously undergone total or subtotal gastrectomy, decompressive percutaneous endoscopic jejunostomy (dPEJ) was performed. In 1/14 patient...Continue Reading

References

Oct 1, 1978·Cancer Nursing·R McCorkle, K Young
May 1, 1991·The American Journal of Hospice & Palliative Care·P S Storey
Jan 1, 1991·Gastrointestinal Endoscopy·M ShikeH Likier
May 1, 1990·Gastrointestinal Endoscopy·M ShikeM F Brennan
Feb 1, 1987·Annals of Surgery·T A Stellato, M W Gauderer
Dec 1, 1980·Journal of Pediatric Surgery·M W GaudererR J Izant
Feb 1, 1996·Gastrointestinal Endoscopy·W VogtA Holstege
Jun 1, 1996·Gynecologic Oncology·G MangiliA Ferrari
Sep 24, 1999·British Journal of Obstetrics and Gynaecology·E TsahalinaD P Barton
Jun 30, 2001·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·C RipamontiUNKNOWN Working Group of the European Association for Palliative Care
Feb 4, 2006·Current Treatment Options in Oncology·Larissa Meyer, Bhavana Pothuri
Mar 15, 2006·Gastroenterology Clinics of North America·Stephen A McClave, Christine S Ritchie
Mar 25, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Carla Ida RipamontiHans Gerdes
Jul 29, 2011·The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology·Somi Mohammad HosseinAntikchi Mohammad Hossein
Jan 24, 2012·Bulletin du cancer·Guillemette LavalUNKNOWN SALTO Study Group
Jan 27, 2012·Critical Reviews in Oncology/hematology·Sebastiano Mercadante, Giampiero Porzio
Jun 19, 2013·Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society·Noboru KawataHiroyuki Ono

❮ Previous
Next ❯

Citations

Apr 14, 2020·Cancer·UNKNOWN Chicago Consensus Working Group
Apr 26, 2017·Current Gastroenterology Reports·Srinivas R Rami Reddy, Mitchell S Cappell
Apr 24, 2017·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Anne DittrichMarkus K Schuler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.